Respiratory & Lung Transplant Physician, Brisbane
Dr John Mackintosh
MBBS(Hons), FRACP — Specialist Respiratory and Lung Transplant Physician
Dr Mackintosh is a Brisbane-based respiratory physician with a subspecialty focus on interstitial lung disease (ILD), including idiopathic pulmonary fibrosis (IPF), connective tissue disease-associated ILD, hypersensitivity pneumonitis, familial ILD and telomere biology disorders. He is a Respiratory & Lung Transplant Physician with the Queensland Lung Transplant Service at The Prince Charles Hospital, and Associate Professor at The University of Queensland.
A subspecialist approach to fibrotic lung disease
Interstitial lung disease is uncommon, and covers a wide range of distinct diseases that can look similar yet behave very differently. Recognising the specific pattern reliably, and knowing when a presentation doesn't fit the expected picture, requires subspecialty expertise.
Dr Mackintosh leads a major public ILD service in Queensland, seeing the full range of conditions, including rare and atypical presentations. This depth of exposure underpins his approach to personalised diagnosis and management. His clinical and research contribution to the field was recognised with his academic promotion to Associate Professor at The University of Queensland.
His involvement in this field extends beyond his own clinic. He founded and chairs the Australasian ILD Genetics Multidisciplinary Meeting — the national forum for familial and genetically complex ILD cases — and co-chairs the Queensland Statewide ILD Multidisciplinary Meeting. Through these forums, he provides diagnosis and management advice to patients and clinicians across Queensland and Australia. He is also a Principal Investigator on a number of ILD clinical trials, keeping his practice up to date with the latest research.
Areas of clinical expertise
Assessment and ongoing management for the following conditions, for patients across Brisbane and Queensland.
Interstitial Lung Disease
Diagnosis and multidisciplinary management of ILD across its many subtypes.
Learn about ILDIdiopathic Pulmonary Fibrosis
Diagnosis, antifibrotic treatment and clinical trial access for IPF.
Learn about IPFProgressive Pulmonary Fibrosis
Management of progressive fibrosing patterns arising in IPF or other fibrotic ILDs.
Learn about PPFConnective Tissue Disease-ILD
Joint respiratory and rheumatology care for ILD associated with connective tissue disease.
Learn about CTD-ILDHypersensitivity Pneumonitis
Identification of inhaled triggers and management of hypersensitivity pneumonitis.
Learn about HPAsbestosis
Assessment and management of pulmonary fibrosis from occupational asbestos exposure.
Learn about asbestosisSarcoidosis
Assessment and management of pulmonary sarcoidosis, including complex and fibrotic disease.
Learn about sarcoidosisFamilial Interstitial Lung Disease
Assessment of pulmonary fibrosis occurring in families, including genetic evaluation and screening of at-risk relatives.
Learn about familial ILDTelomere Biology Disorders
Diagnosis and management of short telomere syndromes presenting with pulmonary fibrosis, including pre- and post-transplant care.
Learn about telomere biology disordersGenetics
Genetic evaluation and testing for pulmonary fibrosis and ILD, including counselling for patients and relatives.
Learn about genetics in ILDLung Transplantation
Assessment and pre/post-transplant management through the Queensland Lung Transplant Service.
Learn about lung transplantationFor referring clinicians
Dr Mackintosh accepts referrals from GPs, rheumatologists and other specialists for assessment and ongoing shared care of patients with suspected or confirmed interstitial lung disease.
Research & guidelines
Dr Mackintosh's research spans ILD genetics, telomere biology and lung transplantation outcomes, and he is first author of Australia and New Zealand's current treatment guidelines for IPF and PPF.